The vaccine industry and the vast ecosystem surrounding it had areas of rapid growth before the pandemic, but it’s exploded as companies race to develop Covid-19 vaccinations, treatments, booster shots and more.
The mRNA technology used in the Moderna and Pfizer-BioNTech vaccines has the potential to fuel more gains at a wider swath of companies and to advance research beyond Covid. Some potential uses: vaccines for Zika, multiple respiratory viruses, melanoma, HIV, Epstein-Barr and malaria. There’s also hope for a more-effective flu vaccine, because current ones generally reduce the risk of illness by only 40% to 60%. Click the link in bio for our breakdown of the playing field and what to watch if you want to invest in the future of vaccines.